Visco Vision Inc (6782) Fair Value & Analysis
Healthcare · TW · Market cap 12.3B TWD
Fair value as of: Jun 24, 2026
Analysis
Visco Vision Inc (6782) currently trades at 194.50 TWD, while our model-based Fair Value estimate is 309.61 TWD — implying the stock looks roughly 59.2% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Visco Vision Inc. manufactures and sells silicone hydrogel contact lenses in Asia, Europe, and the Americas. It offers spherical, multifocal, toric, cosmetic, and color lenses. The company also provides medical and lease management services. Visco Vision Inc. was incorporated in 1998 and is based in Taoyuan City, Taiwan.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Visco Vision Inc (6782) undervalued?
What is the fair value of 6782?
What is the quality score of 6782?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.